Is it Time for Single-Pill Combinations in Dyslipidemia?

Despite the availability of lipid-lowering therapies (LLTs) that are safe and effective, the overall rate of low-density lipoprotein cholesterol (LDL-C) control at a population level in real-life studies is low. Higher-intensity treatment, earlier intervention, and longer-term treatment have all bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiele, François, Pérez de Isla, Leopoldo, Arca, Marcello, Vlachopoulos, Charalambos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061650/
https://www.ncbi.nlm.nih.gov/pubmed/34549371
http://dx.doi.org/10.1007/s40256-021-00498-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061650/
https://www.ncbi.nlm.nih.gov/pubmed/34549371
http://dx.doi.org/10.1007/s40256-021-00498-2

Ejemplares similares